Greg Hattoy is a Senior Manager at Alnylam Pharmaceuticals, leading new product introduction for early stage clinical programs. With previous experience at Alexion Pharmaceuticals, Greg has worked in various roles such as Manufacturing Specialist, Compliance Specialist, and Quality Control Analyst. Greg holds a Bachelor's degree in Biology with a minor in Chemistry from the University of Rhode Island.
July, 2021 - present
July, 2017